Coronavirus: COVID-19 cases on the rise in India, although cure rate has improved
New Delhi:
India reported the highest one-day peak of 45,720 coronavirus cases and 1,129 deaths this morning, according to government data. The total number of cases has now crossed 12 lakh and stands at 12,38,635. To date, 7,820,607 people have recovered, while 29,861 have died. The recovery rate is 63.18% and the positivity rate is 13.03%. The largest number of samples was tested on Wednesday, with 3 50,823 samples collected. The total of samples tested so far exceeds 1.5 crore, according to government data. Maharashtra has the highest number of coronavirus cases in India, followed by Tamil Nadu and Delhi. Maharashtra is struggling with a shortage of life-saving drugs like Remdesivir and Tocilizumab. The state government says it is remedying the shortage and has been in contact with suppliers to increase supplies.
Here’s your 10-point cheat sheet for this great story:
-
The five states that have reported the highest number of COVID-19 cases in the past 24 hours are: Maharashtra (10,576), Andhra Pradesh (6,045), Tamil Nadu (5,849), Karnataka (4,764) and Uttar Pradesh (2,300).
-
The five states that reported the highest deaths in the past 24 hours are: Tamil Nadu (518), Maharashtra (280), Andhra Pradesh (65), Karnataka (55) and West Bengal ( 39).
-
Several states have declared full lockdowns of their cities as coronavirus cases continue to rise. India has the highest number of coronavirus cases after the United States and Brazil.
-
West Bengal’s first 24-hour bi-weekly lockdown begins today, a day after the state recorded the highest number of new cases at 2,291 and the highest number of deaths at 39 in the space of 24 hours.
-
Delhi has decided to conduct serological surveys every month to develop better policies to combat COVID-19, Health Minister Satyendar Jain said on Wednesday. The move comes after the state government analyzed the results of the latest serological survey, which showed 23% of people in Delhi have been exposed to the coronavirus.
-
Human trials of the locally developed coronavirus vaccine, COVAXIN, began on July 20, AIIMS-Delhi director Dr Randeep Guleria said, adding that researchers would need at least three months to get to the first set of data.
-
Researchers are making “good progress” in developing COVID-19 vaccines, with a handful of late-stage trials, but their first use cannot be expected until early 2021, said Mike Ryan, head of COVID-19. World Health Organization (WHO) emergency program. Wednesday. “In fact, it will be the first part of next year before we start seeing people getting vaccinated,” he said at a public event on social media.
-
Tamil Nadu, Delhi and other states have started plasma banks. Plasma donation has been encouraged as an experimental treatment for patients with COVID-19. Antibody-rich plasma from a person who has recovered from COVID-19 could help an infected person fight off the virus, research shows.
-
At least 15,007,291 cases of coronavirus, including 617,603 deaths, have been detected worldwide since the pandemic emerged late last year, AFP news agency reported. Africa, where an acceleration of cases concerns the WHO, has passed the 15,000 death mark.
-
The US government has agreed to pay $ 1.95 billion to obtain 100 million doses of a potential vaccine against the coronavirus under development by US pharmaceutical giant Pfizer and Germany Biontech.
